These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Successful use of danaparoid in the treatment of portal vein thrombosis that developed in a warfarin-administered hepatitis C virus-related cirrhosis patient]. Nawata Y; Hamada K; Tajima H; Nishino N; Nakazawa T; Tobayashi K; Saitoh S Nihon Shokakibyo Gakkai Zasshi; 2012 Aug; 109(8):1394-400. PubMed ID: 22863964 [TBL] [Abstract][Full Text] [Related]
4. Portal vein thrombosis treated using danaparoid sodium and antithrombin III. Uchiyama T; Hirokazu T; Hosono K; Endo H; Akiyama T; Yoneda K; Inamori M; Abe Y; Kubota K; Saito S; Nakajima A Hepatogastroenterology; 2010; 57(97):52-3. PubMed ID: 20422871 [TBL] [Abstract][Full Text] [Related]
6. A case in which danaparoid sodium was effective for portal venous thrombosis developed after endoscopic injection sclerotherapy for esophageal varices. Shudo R; Yazaki Y; Honda M; Sugawara K Clin J Gastroenterol; 2008 Oct; 1(3):110-115. PubMed ID: 26193648 [TBL] [Abstract][Full Text] [Related]
7. The endoscopic ultrasound probe findings in prediction of esophageal variceal recurrence after endoscopic variceal eradication therapies in cirrhotic patients: a cohort prospective study. Zheng J; Zhang Y; Li P; Zhang S; Li Y; Li L; Ding H BMC Gastroenterol; 2019 Feb; 19(1):32. PubMed ID: 30782139 [TBL] [Abstract][Full Text] [Related]
8. Portal vein thrombosis in children and adolescents: 20 years experience of a pediatric hepatology reference center. Ferri PM; Ferreira AR; Fagundes ED; Liu SM; Roquete ML; Penna FJ Arq Gastroenterol; 2012; 49(1):69-76. PubMed ID: 22481689 [TBL] [Abstract][Full Text] [Related]
9. The effects of chronic endoscopic variceal sclerotherapy on portal pressure in cirrhotics. Korula J; Ralls P Gastroenterology; 1991 Sep; 101(3):800-5. PubMed ID: 1860642 [TBL] [Abstract][Full Text] [Related]